Parmax Pharma (BOM:540359) Marketable Securities : ₹0.0 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Parmax Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Parmax Pharma's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Parmax Pharma Marketable Securities Historical Data

The historical data trend for Parmax Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parmax Pharma Marketable Securities Chart

Parmax Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

Parmax Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Parmax Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Parmax Pharma (BOM:540359) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Parmax Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Parmax Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Parmax Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parmax Pharma Ltd (BOM:540359) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

Rajkot-Gondal National Highway No. 27, Plot No. 20, Survey No. 52, Taluka Kotda Sangani, Hadamtala, Rajkot, GJ, IND, 360 311

Website

https://www.parmaxpharma.com

Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and injectables. Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.

Parmax Pharma Headlines

No Headlines